Avalo Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2025 | 1.04 M | $8.30 M | 0.00% | 9.86% |
| ORBIMED ADVISORS LLC | 05/15/2025 | 967.00 K | $7.75 M | 0.00% | 9.20% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 967.00 K | $7.75 M | 0.00% | 9.20% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 900.00 K | $7.21 M | 100.00% | 8.56% |
| DEEP TRACK CAPITAL, LP | 05/15/2025 | 859.88 K | $6.89 M | -0.82% | 8.18% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 657.15 K | $5.26 M | 19.32% | 6.25% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 520.00 K | $4.17 M | 100.00% | 4.95% |
| COMMODORE CAPITAL LP | 05/15/2025 | 483.00 K | $3.87 M | 0.00% | 4.59% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/14/2025 | 483.00 K | $3.87 M | 0.00% | 4.59% |
| ADVISER INVESTMENTS LLC | 05/13/2025 | 312.78 K | $2.51 M | 100.00% | 2.97% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 200.00 K | $1.60 M | -79.39% | 1.90% |
| VANGUARD GROUP INC | 05/09/2025 | 166.94 K | $1.34 M | 0.69% | 1.59% |
| BLACKROCK, INC. | 05/02/2025 | 133.73 K | $1.07 M | 0.37% | 1.27% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 111.97 K | $896.90 K | 1.82% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 107.81 K | $864.39 K | 2.82% | 1.03% |
| ALLOSTERY INVESTMENTS LP | 05/15/2025 | 107.14 K | $858.20 K | 46.14% | 1.02% |
| UBS GROUP AG | 05/13/2025 | 98.95 K | $792.60 K | 0.44% | 0.94% |
| SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 71.46 K | $572.38 K | 0.00% | 0.68% |
| NORTHERN TRUST CORP | 05/13/2025 | 22.67 K | $181.61 K | 0.00% | 0.22% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 20.22 K | $161.99 K | 3.83% | 0.19% |
| HRT FINANCIAL LP | 05/15/2025 | 10.29 K | $82.00 K | -74.28% | 0.10% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 10.00 K | $80.10 K | 100.00% | 0.10% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.67 K | $45.44 K | 0.05% | 0.05% |
| JPMORGAN CHASE & CO | 05/12/2025 | 1.11 K | $8.85 K | 55,150.00% | 0.01% |
| MORGAN STANLEY | 05/15/2025 | 360 | $2.88 K | 3,500.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2025 | 212 | $2.00 K | -99.82% | 0.00% |
| 05/02/2025 | 22 | $176 | 0.00% | 0.00% | |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 4 | $32 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 2 | $16 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 2 | $16 | 0.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 04/08/2025 | 1 | $8 | 0.00% | 0.00% |
| KEY FINANCIAL INC | 05/01/2025 | 1 | $8 | 0.00% | 0.00% |
| ACTIVEST WEALTH MANAGEMENT | 05/15/2025 | 1 | $8 | 0.00% | 0.00% |
| BANK OF MONTREAL /CAN/ | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avalo Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of Avalo Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 1.04 M
RA CAPITAL MANAGEMENT, L.P.: 967,000
ORBIMED ADVISORS LLC: 967,000
Nantahala Capital Management, LLC: 900,000
Deep Track Capital, LP: 859,876
Affinity Asset Advisors, LLC: 657,154
78.51% of Avalo Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 8.30 M shares in the last 24 months. This purchase volume represents approximately $38.26 M in transactions.